Systolic and diastolic blood pressure control in antihypertensive drug trials

被引：202

作者：

Mancia, G

Grassi, G

机构：

[1] Univ Milano Bicocca, Med Clin, Osped San Gerardo, Dipartimento Med Prevenz & Biotecnol Sanitarie, I-20052 Milan, Italy

[2] Ctr Interuniv Fisiol Clin & Ipertens, Milan, Italy

[3] Ist Auxol Italiano, Milan, Italy

来源：

JOURNAL OF HYPERTENSION | 2002年 / 20卷 / 08期

关键词：

D O I：

10.1097/00004872-200208000-00001

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：1461 / 1464

页数：4

共 35 条

[11] Shanghai trial of nifedipine in the elderly (STONE) [J].

Gong, LS ;

Zhang, WZ ;

Zhu, YJ ;

Zhu, JR ;

Kong, DW ;

Page, V ;

Ghadirian, P ;

LeLorier, J ;

Hamet, P .

JOURNAL OF HYPERTENSION, 1996, 14 (10) :1237-1245

[12] Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study [J].

Hansson, L ;

Hedner, T ;

Lund-Johansen, P ;

Kjeldsen, SE ;

Lindholm, LH ;

Syvertsen, JO ;

Lanke, J ;

de Faire, U ;

Dahlöf, B ;

Karlberg, BE .

LANCET, 2000, 356 (9227) :359-365

[13] Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].

Hansson, L ;

Lindholm, LH ;

Niskanen, L ;

Lanke, J ;

Hedner, T ;

Niklason, A ;

Luomanmäki, K ;

Dahlöf, B ;

de Faire, U ;

Mörlin, C ;

Karlberg, BE ;

Wester, PO ;

Björck, JE .

LANCET, 1999, 353 (9153) :611-616

[14] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study [J].

Hansson, L ;

Lindholm, LH ;

Ekbom, T ;

Dahlöf, B ;

Lanke, J ;

Scherstén, B ;

Wester, PO ;

Hedner, T ;

de Faire, U .

LANCET, 1999, 354 (9192) :1751-1756

[15] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[16] SYSTOLIC VERSUS DIASTOLIC BLOOD PRESSURE AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY [J].

KANNEL, WB ;

GORDON, T ;

SCHWARTZ, MJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1971, 27 (04) :335-&

[17] Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries -: Principal results from EUROASPIRE II Euro Heart Survey Programme [J].

Kotseva, K ;

Wood, D ;

De Backer, G ;

De Bacquer, D ;

Pyöräla, K ;

Keil, U .

EUROPEAN HEART JOURNAL, 2001, 22 (07) :554-572

[18]

LEVY D, 1999, J HYPERTENS S1, V17, pS5

[19] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].

Lewis, EJ ;

Hunsicker, LG ;

Clarke, WR ;

Berl, T ;

Pohl, MA ;

Lewis, JB ;

Ritz, E ;

Atkins, RC ;

Rohde, R ;

Raz, I .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860

[20] Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients:: results from the Swedish Trial in Old Patients with Hypertension -: 2 [J].

Lindholm, LH ;

Hansson, L ;

Ekbom, T ;

Dahlöf, B ;

Lanke, J ;

Linjer, E ;

Scherstén, B ;

Wester, PO ;

Hedner, T ;

de Faire, U .

JOURNAL OF HYPERTENSION, 2000, 18 (11) :1671-1675

← 1 2 3 4 →